|
UHRF1BP1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.87059999999995E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.022700E-03 |
| Normal-vs-Stage2 |
5.777300E-03 |
| Normal-vs-Stage3 |
3.92339999999436E-06 |
| Normal-vs-Stage4 |
6.302500E-03 |
| Stage1-vs-Stage2 |
5.244400E-01 |
| Stage1-vs-Stage3 |
5.603500E-02 |
| Stage1-vs-Stage4 |
5.174800E-01 |
| Stage2-vs-Stage3 |
4.404200E-01 |
| Stage2-vs-Stage4 |
9.604400E-01 |
| Stage3-vs-Stage4 |
4.074400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.7071699999982E-05 |
| Normal-vs-AfricanAmerican |
1.248380E-01 |
| Normal-vs-Asian |
3.192200E-01 |
| Caucasian-vs-AfricanAmerican |
4.230000E-01 |
| Caucasian-vs-Asian |
5.204500E-02 |
| AfricanAmerican-vs-Asian |
2.306000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.99967999999773E-05 |
| Normal-vs-Female |
3.002200E-03 |
| Male-vs-Female |
2.468000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.211700E-02 |
| Normal-vs-Age(41-60Yrs) |
2.599500E-03 |
| Normal-vs-Age(61-80Yrs) |
4.0275000000034E-05 |
| Normal-vs-Age(81-100Yrs) |
3.617600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.725400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.238600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.481800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.047400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.401760E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.063200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.529000E-01 |
| Normal-vs-Grade 2 |
9.628500E-04 |
| Normal-vs-Grade 3 |
3.383400E-04 |
| Normal-vs-Grade 4 |
2.973900E-04 |
| Grade 1-vs-Grade 2 |
5.682800E-01 |
| Grade 1-vs-Grade 3 |
4.787600E-01 |
| Grade 1-vs-Grade 4 |
2.520400E-01 |
| Grade 2-vs-Grade 3 |
6.265400E-01 |
| Grade 2-vs-Grade 4 |
1.750850E-01 |
| Grade 3-vs-Grade 4 |
3.430800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.007500E-04 |
| Normal-vs-ccB subtype |
8.685000E-03 |
| ccA subtype-vs-ccB subtype |
4.403600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.941030E-03 |
| Normal-vs-N1 |
7.443600E-01 |
| N0-vs-N1 |
6.520400E-01 |
|
|
